Loading organizations...
Loading organizations...
Cell therapies to restore immunity against virus-associated diseases.
AlloVir has raised $129.0M across 2 funding rounds.
AlloVir has raised $129.0M in total across 2 funding rounds.
AlloVir has raised $129.0M in total across 2 funding rounds.
AlloVir's investors include Fidelity Management & Research Company, Cancer Prevention and Research Institute of Texas.
AlloVir has raised $129.0M across 2 funding rounds. Most recently, it raised $120.0M Series B in May 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 30, 2019 | $120.0M Series B | Fidelity Management & Research Company | |
| Aug 21, 2017 | $9.0M Grant | Cancer Prevention and Research Institute of Texas |